Skip to content

ICU Medical ICUI Derivative Assets - Fair Value

Derivative Assets - Fair Value at other companies

Baxter International logo
Baxter InternationalBAX
Edwards Lifesciences logo
Edwards LifesciencesEW
Medtronic logo
MedtronicMDT
LivaNova logo
LivaNovaLIVN
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:DerivativeAssetsNoncurrent.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's derivative assets - fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's derivative assets - fair value?
ICU Medical (ICUI) reported derivative assets - fair value of $759K in Q1 2026.
How has ICU Medical's derivative assets - fair value changed year-over-year?
ICU Medical's derivative assets - fair value increased by 48.2% year-over-year, from $512K to $759K.
What is the long-term trend for ICU Medical's derivative assets - fair value?
Over 4 years (2021 to 2025), ICU Medical's derivative assets - fair value has grown at a -16.1% compound annual growth rate (CAGR), from $1.48M to $734K.